References
- Furches BJ. Alkanolamines in creams and lotions. Cosmet Toiletries 1980; 95: 63–66
- Final report on the safety assessment of triethanolamine, diethanolamine, and monoethanolamine. J Am Coll Toxicol 1983; 7: 183–235
- Melnick RL, Tomaszewski KE. Triethanolamine. Ethyl Browning's Toxicity and Metabolism of Industrial Solvents, DR Buhler, DJ Reed. 2nd ed., Elsevier Science Publishers, New York 1990
- National Toxicology Program Technical Report, TR-449, Toxicology and Carcinogenesis Studies of Triethanolamine in F344 Rats and B6C3F1 Mice. NIH Pub. No. 00-3365; 1999.
- Stott WT, Waechter JM, Jr, Rick DL, Mendrala AL. Absorption, distribution, metabolism and excretion of intravenously and dermally administered triethanolamine in mice. Fd Chem Toxicol 2000; 38: 1043–1051
- Bronaugh RL, Hood HL, Kraeling MEK, Yourick JJ. Determination of percutaneous absorption by in vitro techniques. Percutaneous Absorption: Drugs–Cosmetics–Mechanisms–Methodology, RL Bronaugh, HI Maibach. Marcel Dekker, Inc., New York 1999
- Kraeling MEK, Bronaugh RL. In vitro percutaneous absorption of alpha hydroxy acids in human skin. J Soc Cosmet Chem 1997; 48: 187–197
- Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies IV: the flow-through diffusion cell. J Pharm Sci 1985; 74: 64–67
- Collier SW, Sheikh NM, Sakr A, Stewart RF, Bronaugh RL. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies. Toxicol Appl Pharmacol 1989; 99: 522–533
- Bronaugh RL, Stewart RF, Simon M. Methods for in vitro percutaneous absorption studies VII: use of excised human skin. J Pharm Sci 1986; 75: 1094–1097
- Rabinowitz JL, Feldman ES, Weinberger A, Schumacher HR. Comparative tissue absorption of oral 14C-Aspirin and topical triethanolamine 14C-Salicylate in human and canine knee joints. J Clin Pharmacol 1982; 22: 42–48
- Kraeling ME, Jung CT, Yourick JJ, Bronaugh RL. In vitro percutaneous absorption of diethanolamine (DEA) in human skin. Toxicologist 2002; 66(1), Abstract No. 807